Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

Sector: Healthcare   

Industry: Biotechnology

8.01
 
USD
  
0.06
  
(0.75%)
Optionable: Yes  Market Cap: 653 M  90-day average vol: 1,026,562

Previous close: 7.95  Open: 8.09  Bid: 8.01  Ask: 8.1
52 week range    
4.90   
   11.93
Peers   
LGND / 
ABIO / 
PTN / 
CORT / 
Last updated: Thursday 7th December 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABIO

0 B-1.21.94

BCRX

3 B-12.216.38

CORT

2 B22.619.69

LGND

2 B31.2124.04

PTN

0 B-30.427
Financials

AVXL Income Statement

Annual
Sep-14Sep-15Sep-16Sep-17Sep-18Sep-19Sep-20Sep-21Sep-22Sep-23
Basic EPS from continuing operations-0.6
Basic EPS total-1.16-2.6-0.42-0.6
Basic weighted shares outstanding10 M5 M35 M41 M45 M49 M58 M70 M80 M
Diluted EPS total-1.2-2.6-0.42-0.33-0.39-0.54-0.45-0.54-0.6
Diluted normalized net income/share-0.45-0.54-0.6
Diluted weighted shares outstanding10 M5 M35 M41 M44 M49 M58 M70 M80 M
Fees-9 M-5 M-5812.0-30943.0-151133.0
GeneralAndAdministrativeExpense2 M5 M8 M5 M6 M7 M6 M9 M13 M12 M
Gross operating profit-9 M-5 M-5812.0-30943.0-151133.0
Income before tax-11 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-47 M
Income restructuring and M&A-2 M-5 M
Income taxes-1 M5000.029615.059607.072746.082181.022664.0267565.0358000.07000.0
Interest income199655.0924895.02 M2 M3 M5 M5 M
InterestExpenseNonOperating7089.071825.0-179973.0-26261.0-947000.0-7 M
MiscOtherSpecialCharges2 M7 M61205.02 M115758.0443831.03 M2 M
Net income from total operations-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
NetIncomeCommonStockholders-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
NetIncomeContinuousOperations-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
NetNonOperatingInterestIncomeExpense192566.0-71825.0924895.02 M2 M3 M5 M5 M947000.07 M
NetOperatingInterestIncomeExpense-71825.011322.088098.0255092.0207280.0
Normalized income-38 M
Operating income-12 M-12 M-16 M-16 M-19 M-29 M-31 M-42 M-51 M-56 M
Operating income before depreciation (EBITDA)-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-49 M-54 M
OperatingExpense-3 M-7 M-16 M-16 M-19 M-29 M31 M42 M51 M56 M
Other income net-2 M-7 M-61205.0-2 M-115758.0-443831.0-3 M-2 M
OtherGandA2 M5 M8 M5 M6 M7 M6 M9 M13 M12 M
OtherOperatingExpenses73000.0118000.0
OtherTaxes-72746.0-82181.0-22664.0-267565.0358000.0
RentAndLandingFees2 M5 M8 M5 M6 M7 M-233423.0-130784.072865.0
Research & development expense732395.02 M7 M11 M13 M22 M25 M33 M38 M44 M
ResearchExpense732395.02 M7 M11 M13 M22 M25 M33 M38 M44 M
RestructringAndMnAIncome-2 M-5 M
SalariesAndWages-413979.0-5 M-4 M-6 M-6 M-5 M-8 M18 M16 M
Selling Gen & administrative expense2 M5 M8 M5 M6 M7 M6 M9 M13 M12 M
SellingAndMarketingExpense-1 M-3 M
Special income/charges2 M5 M
Total Income available for interest expense (EBIT)-11 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-49 M-54 M
Total common shares outstanding14 M9 M40 M44 M47 M56 M67 M76 M82 M
Total net income-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
Total ordinary shares82 M82 M82 M82 M82 M82 M82 M82 M82 M82 M
Total revenues-9 M-5 M-5812.0-30943.0-151133.0
TotalExpenses-3 M-7 M-16 M-16 M-19 M-29 M31 M42 M51 M56 M
TotalRevenue-9 M-5 M-5812.0-30943.0-151133.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today